Back
Amicus Therapeutics Stock Price Chart
Buffet, Bloomberg & 48 Congress Members Are Buying 1 Sector
Click here for the details.
Sell
47
FOLD
Amicus Therapeutics
Last Price:
9.82
Seasonality Move:
9.11%
7 Day Trial
ALL ACCESS PASS
$
7
What's Nvidia doing next??
Click here now to learn more about Nvidia's next AI move.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing selling pressure, which indicates risk of future bearish movement.
Amicus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.86 | Sell |
| 20-day SMA: | 10.06 | Sell |
| 50-day SMA: | 9.97 | Sell |
| 200-day SMA: | 11.48 | Sell |
| 8-day EMA: | 9.87 | Sell |
| 20-day EMA: | 9.94 | Sell |
| 50-day EMA: | 10.2 | Sell |
| 200-day EMA: | 11.25 | Sell |
Amicus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 45.89 | Sell |
| Chaikin Money Flow: | -511076 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.73 - 10.31) | Sell |
| Bollinger Bands (100): | (9.71 - 12.41) | Sell |
Amicus Therapeutics Technical Analysis
| Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics Stock
Is Amicus Therapeutics Stock a Buy?
- Amicus Therapeutics share price is 9.81 while FOLD 8-day simple moving average is 9.86, which is a Sell signal.
- The stock price of FOLD is 9.81 while Amicus Therapeutics 20-day SMA is 10.06, which makes it a Sell.
- Amicus Therapeutics 50-day simple moving average is 9.97 while FOLD share price is 9.81, making it a Sell technically.
- FOLD stock price is 9.81 and Amicus Therapeutics 200-day simple moving average is 11.48, creating a Sell signal.
FOLD Technical Analysis vs Fundamental Analysis
Sell
47
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a Sell
The current Amicus Therapeutics [FOLD] share price is $9.81. The Score for FOLD is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Amicus Therapeutics Stock Info
Market Cap:
2.91B
Price in USD:
9.81
Share Volume:
511.08K
Amicus Therapeutics 52-Week Range
52-Week High:
14.57
52-Week Low:
9.02
Sell
47
Amicus Therapeutics (FOLD)
is a Sell
Amicus Therapeutics Share Price Forecast
-
What is the Amicus Therapeutics stock price today?
The Amicus Therapeutics stock price is 9.81 USD today. -
Will FOLD stock go up or go down?
Amicus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Amicus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics is overvalued.
Is Amicus Therapeutics Stock a Buy?
- Amicus Therapeutics share price is 9.81 while FOLD 8-day exponential moving average is 9.87, which is a Sell signal.
- The stock price of FOLD is 9.81 while Amicus Therapeutics 20-day EMA is 9.94, which makes it a Sell.
- Amicus Therapeutics 50-day exponential moving average is 10.20 while FOLD share price is 9.81, making it a Sell technically.
- FOLD stock price is 9.81 and Amicus Therapeutics 200-day simple moving average is 11.25, creating a Sell signal.
Fundamental Analysis of Amicus Therapeutics
Is Amicus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.02 per share, an increase this year of $0.55 per share, and an increase next year of $0.32 per share.
Technical Analysis of Amicus Therapeutics
Should I short Amicus Therapeutics stock?
- FOLD Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting Amicus Therapeutics is a Sell
- Amicus Therapeutics Relative Strength Index (RSI) is 45.89, which suggest Amicus Therapeutics is oversold
- The Bollinger Bands (25) for Amicus Therapeutics is (9.73 - 10.31), which suggest Amicus Therapeutics is a Sell
- The Bollinger Bands (100) for Amicus Therapeutics is (9.71 - 12.41), which suggest Amicus Therapeutics is a Sell
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.